Journal
NAR CANCER
Volume 5, Issue 4, Pages -Publisher
OXFORD UNIV PRESS
DOI: 10.1093/narcan/zcad052
Keywords
-
Categories
Ask authors/readers for more resources
This article briefly reviews the details of the CIP2A-TopBP1 interaction, explores their roles in maintaining genome integrity and cancer development, as well as the potential of CIP2A as a therapeutic target.
CIP2A is an inhibitor of the tumour suppressor protein phosphatase 2A. Recently, CIP2A was identified as a synthetic lethal interactor of BRCA1 and BRCA2 and a driver of basal-like breast cancers. In addition, a joint role of TopBP1 (topoisomerase II beta-binding protein 1) and CIP2A for maintaining genome integrity during mitosis was discovered. TopBP1 has multiple functions as it is a scaffold for proteins involved in DNA replication, transcriptional regulation, cell cycle regulation and DNA repair. Here, we briefly review details of the CIP2A-TopBP1 interaction, its role in maintaining genome integrity, its involvement in cancer and its potential as a therapeutic target. Graphical Abstract
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available